Related Experiment Video
Updated: May 8, 2026
07:41
Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
Published on: October 23, 2020
[Diabetes and driving: evidence and recommendations]
Catarina Senra Moniz1, Filipa Alves Serra, Rute Costa Ferreira
1Serviço de Endocrinologia, Diabetes e Metabolismo. Hospital de Egas Moniz. Lisboa. Portugal.. catarinasenra@gmail.com.
Acta Medica Portuguesa
|September 11, 2013
Summary
Diabetic drivers face increased road risks due to hypoglycemia and complications. New Portuguese regulations assess fitness to drive based on hypoglycemia history and diabetes control.
Area of Science:
- Medical Science
- Public Health
- Road Safety
Context:
- Growing concern regarding medical conditions and driving safety.
- Diabetes mellitus identified as a risk factor for road traffic accidents.
- Hypoglycemia and diabetes-related complications (retinopathy, cataracts, neuropathy) increase driving risks.
Purpose:
- To highlight the risks associated with diabetes and driving.
- To outline essential safety measures for diabetic drivers.
- To detail recent regulatory changes for diabetic drivers in Portugal.
Summary:
- Diabetic individuals are at higher risk of accidents due to hypoglycemia and long-term complications.
- Key recommendations include monitoring blood glucose, carrying sugar sources, and recognizing hypoglycemia symptoms.
- Portuguese regulations since 2013 classify drivers based on hypoglycemia severity and require medical reports for Group 2 drivers.
Impact:
- Aims to improve road safety for diabetic drivers.
- Promotes better diabetes management and awareness among drivers.
- Provides a framework for assessing the driving eligibility of individuals with diabetes.
Related Concept Videos
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...